Bhanji Muna
- SEC CIK
- 0001846905
In the past year, 1 open-market sale filing worth $80.1K and no purchases.
Current role at each company
- VCYT Veracyte, Inc.Directoras of Sep 3, 2026
- ARDX Ardelyx, Inc.Directoras of Jun 18, 2026
- NTLA Intellia Therapeutics, Inc.Directoras of Jun 10, 2026
- CYTK Cytokinetics IncDirectoras of May 27, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $80.1K
- 1 filing
- Net
- −$80.1K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Bhanji Muna as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
VCYT Veracyte, Inc.
Director6 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 1, 2023 (view filing) | May 30 | 2 days | Bhanji MunaDirector | SSale | −1.54K | $25.91 | −$39.9K | −5.9%24.7K after | |
| Jun 21, 2023 (view filing) | Jun 16 | 5 days | Bhanji MunaDirector | SSale | −5.89K | $26.43 | −$155.8K | −17.1%28.5K after | 2 lots10b5-1 |
| May 30, 2024 (view filing) | May 28 | 2 days | Bhanji MunaDirector | SSale | −1.54K | $21.00 | −$32.3K | −5.4%27.0K after | 10b5-1 |
| Jun 11, 2024 (view filing) | Jun 10 | 1 day | Bhanji MunaDirector | SSale | −3.87K | $20.32 | −$78.6K | −14.3%23.1K after | 10b5-1 |
| Jun 17, 2025 (view filing) | Jun 13 | 4 days | Bhanji MunaDirector | SSale | −4.59K | $26.67 | −$122.4K | −13.3%30.0K after | 10b5-1 |
| Sep 3, 2026 (view filing)4:48 PM ET | Sep 1 | 2 days | Bhanji MunaDirector | SSale | −1.86K | $42.97 | −$80.1K | −4.2%42.7K after | 10b5-1 |
CYTK Cytokinetics Inc
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 7, 2023 (view filing) | Jul 7 | Same day | Bhanji MunaDirector | SSale | −2.00K | $34.12 | −$68.2K | −12.5%14.0K after | 10b5-1 |
| Jun 10, 2024 (view filing) | Jun 10 | Same day | Bhanji MunaDirector | SSale | −2.00K | $52.07 | −$104.1K | −10.2%17.6K after | 10b5-1 |
| May 15, 2025 (view filing) | May 15 | Same day | Bhanji MunaDirector | SSale | −1.45K | $29.73 | −$43.2K | −5.8%23.5K after | 10b5-1 |
NTLA Intellia Therapeutics, Inc.
Director5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 10, 2023 (view filing) | Jul 6 | 4 days | Bhanji MunaDirector | SSale | −1.87K | $39.30 | −$73.4K | −13.0%12.5K after | 10b5-1 |
| Aug 2, 2023 (view filing) | Jul 31 | 2 days | Bhanji MunaDirector | SSale | −265 | $42.33 | −$11.2K | −2.1%12.3K after | 10b5-1 |
| Nov 2, 2023 (view filing) | Oct 31 | 2 days | Bhanji MunaDirector | SSale | −265 | $23.90 | −$6.33K | −2.2%12.0K after | 10b5-1 |
| Jan 31, 2025 (view filing) | Jan 29 | 2 days | Bhanji MunaDirector | SSale | −265 | $9.97 | −$2.64K | −1.3%19.5K after | 10b5-1 |
| May 1, 2025 (view filing) | Apr 29 | 2 days | Bhanji MunaDirector | SSale | −265 | $8.50 | −$2.25K | −1.4%19.2K after | 10b5-1 |